These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 20505116)
21. Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene. Barbieri I; Quaglino E; Maritano D; Pannellini T; Riera L; Cavallo F; Forni G; Musiani P; Chiarle R; Poli V Mol Carcinog; 2010 Feb; 49(2):114-20. PubMed ID: 20027636 [TBL] [Abstract][Full Text] [Related]
22. p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling. Hulit J; Lee RJ; Li Z; Wang C; Katiyar S; Yang J; Quong AA; Wu K; Albanese C; Russell R; Di Vizio D; Koff A; Thummala S; Zhang H; Harrell J; Sun H; Muller WJ; Inghirami G; Lisanti MP; Pestell RG Cancer Res; 2006 Sep; 66(17):8529-41. PubMed ID: 16951165 [TBL] [Abstract][Full Text] [Related]
24. ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells. Klos KS; Wyszomierski SL; Sun M; Tan M; Zhou X; Li P; Yang W; Yin G; Hittelman WN; Yu D Cancer Res; 2006 Feb; 66(4):2028-37. PubMed ID: 16489002 [TBL] [Abstract][Full Text] [Related]
25. Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway. Cowell LN; Graham JD; Bouton AH; Clarke CL; O'Neill GM Oncogene; 2006 Dec; 25(58):7597-607. PubMed ID: 16799644 [TBL] [Abstract][Full Text] [Related]
26. EGFR, ErbB2 and Ras but not Src suppress RhoB expression while ectopic expression of RhoB antagonizes oncogene-mediated transformation. Jiang K; Delarue FL; Sebti SM Oncogene; 2004 Feb; 23(5):1136-45. PubMed ID: 14647415 [TBL] [Abstract][Full Text] [Related]
27. Involvement of tyrosine phosphorylation of p185(c-erbB2/neu) in tumorigenicity induced by X-rays and the neu oncogene in human breast epithelial cells. Kang KS; Sun W; Nomata K; Morita I; Cruz A; Liu CJ; Trosko JE; Chang CC Mol Carcinog; 1998 Apr; 21(4):225-33. PubMed ID: 9585252 [TBL] [Abstract][Full Text] [Related]
28. Genetically targeted T cells eradicate established breast cancer in syngeneic mice. Wang H; Wei H; Zhang R; Hou S; Li B; Qian W; Zhang D; Kou G; Dai J; Guo Y Clin Cancer Res; 2009 Feb; 15(3):943-50. PubMed ID: 19188165 [TBL] [Abstract][Full Text] [Related]
29. Expression of a phosphorylated substrate domain of p130Cas promotes PyMT-induced c-Src-dependent murine breast cancer progression. Zhao Y; Kumbrink J; Lin BT; Bouton AH; Yang S; Toselli PA; Kirsch KH Carcinogenesis; 2013 Dec; 34(12):2880-90. PubMed ID: 23825155 [TBL] [Abstract][Full Text] [Related]
30. Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo. Lahlou H; Sanguin-Gendreau V; Frame MC; Muller WJ Breast Cancer Res; 2012 Feb; 14(1):R36. PubMed ID: 22373082 [TBL] [Abstract][Full Text] [Related]
31. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Alimandi M; Romano A; Curia MC; Muraro R; Fedi P; Aaronson SA; Di Fiore PP; Kraus MH Oncogene; 1995 May; 10(9):1813-21. PubMed ID: 7538656 [TBL] [Abstract][Full Text] [Related]
32. Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in mice. Lee C; Dhillon J; Wang MY; Gao Y; Hu K; Park E; Astanehe A; Hung MC; Eirew P; Eaves CJ; Dunn SE Cancer Res; 2008 Nov; 68(21):8661-6. PubMed ID: 18974106 [TBL] [Abstract][Full Text] [Related]
34. Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cells. Trost TM; Lausch EU; Fees SA; Schmitt S; Enklaar T; Reutzel D; Brixel LR; Schmidtke P; Maringer M; Schiffer IB; Heimerdinger CK; Hengstler JG; Fritz G; Bockamp EO; Prawitt D; Zabel BU; Spangenberg C Cancer Res; 2005 Feb; 65(3):840-9. PubMed ID: 15705882 [TBL] [Abstract][Full Text] [Related]
35. Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas/ErbB2 breast cancer invasion. Sciortino M; Camacho-Leal MDP; Orso F; Grassi E; Costamagna A; Provero P; Tam W; Turco E; Defilippi P; Taverna D; Cabodi S Sci Rep; 2017 Apr; 7(1):1145. PubMed ID: 28442738 [TBL] [Abstract][Full Text] [Related]
36. C-Src activation by ErbB2 leads to attachment-independent growth of human breast epithelial cells. Sheffield LG Biochem Biophys Res Commun; 1998 Sep; 250(1):27-31. PubMed ID: 9735325 [TBL] [Abstract][Full Text] [Related]
37. Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signaling. Liu B; Ordonez-Ercan D; Fan Z; Huang X; Edgerton SM; Yang X; Thor AD Mol Cancer Res; 2009 Nov; 7(11):1882-92. PubMed ID: 19861407 [TBL] [Abstract][Full Text] [Related]
38. Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis. Sin S; Bonin F; Petit V; Meseure D; Lallemand F; Bièche I; Bellahcène A; Castronovo V; de Wever O; Gespach C; Lidereau R; Driouch K J Natl Cancer Inst; 2011 Sep; 103(17):1323-37. PubMed ID: 21832234 [TBL] [Abstract][Full Text] [Related]